Nadia Mazarakis Asia-Pacific Vaccine and Immunotherapy Congress 2026

Abstracts this author is presenting:

• Persistence of IgG4 skewing over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine — Oral Presentations #1